T. Nakagawachi

发表

Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer

M. Emi, T. Mukai, Y. Nakabeppu, 2003, Oncogene.

Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours

T. Mukai, Y. Kaneko, H. Soejima, 2006, British Journal of Cancer.

CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection

T. Mukai, Y. Nakabeppu, M. Sekiguchi, 2003, British Journal of Cancer.

Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.

T. Mukai, Y. Kaneko, H. Soejima, 2003, Journal of biochemistry.

The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.

T. Mukai, Wei Zhao, H. Soejima, 2005, Journal of biochemistry.

Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA methylation analysis reveals that DMR-Lit1 is a putative imprinting control region.

T. Mukai, H. Morisaki, H. Soejima, 2002, Genome research.

Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA methylation analysis reveals that DMR-Lit1 is a putative imprinting control region.

T. Mukai, H. Morisaki, H. Soejima, 2004, Genome research.

Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer

M. Oshimura, T. Mukai, Wei Zhao, 2004, Oncogene.

Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.

H. Soejima, K. Miyazaki, Y. Koga, 2005, Oncology reports.